Barbados vs Guatemala: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Barbados
85.0%
in 2025
Guatemala
85.0%
in 2025
Barbados rank
94th
Guatemala rank
94th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Barbados
- Guatemala
How they compare
Barbados currently reports 85.0% against 85.0% in Guatemala, a difference of 0.0%.
The two have swapped places 6 times across 18 shared years of data; in 2008 it was Guatemala ahead.
Barbados ranks 94th and Guatemala ranks 94th of 192 countries.
Across the 3 decades both report, Barbados averaged higher in 2 and Guatemala in 1.
Head to head by decade
| Decade | Barbados | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.5% | 0.0% | 37.5% | Barbados |
| 2010s | 88.4% | 57.9% | 30.5% | Barbados |
| 2020s | 85.5% | 87.7% | 2.2% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Barbados or Guatemala?
- Barbados, at 85.0% against 85.0% in Guatemala as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Barbados and Guatemala?
- 0.0%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Guatemala?
- 18 years are reported by both, from 2008 to 2025.
- How do Barbados and Guatemala rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Barbados ranks 94th and Guatemala ranks 94th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.